Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
PaperCitations, authors & open-access status
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 326 citations, 2024 year and hybrid oa status.
326
Citations
2024
Year
hybrid
OA Status